Cellular immune profiling reveals effector memory CD8(+)CCR5(+) T-cell effect of ocrelizumab in early relapsing-remitting multiple sclerosis
A. Garcia,E. Dugast,S. Shah, J. Morille, C. Lebrun-Frenais,E. Thouvenot,J. De Seze,E. Le Page, S. Vukusic, A. Maurousset, E. Berger,O. Casez, P. Labauge,A. Ruet, C. Raposo,F. Bakdache, R. Buffels, F. Le Frere,A. B. Nicot, S. Wiertlewski,P. -A. Gourraud,L. Berthelot,D. -A. Laplaud MULTIPLE SCLEROSIS JOURNAL（2022）
AI 理解论文
溯源树
样例
